Page last updated: 2024-08-24

capecitabine and glucagon-like peptide 1

capecitabine has been researched along with glucagon-like peptide 1 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Altieri, P; Ameri, P; Armirotti, A; Ballestrero, A; Barisione, C; Borile, S; Brunelli, C; Canepa, M; Carbone, F; Fabbi, P; Garibaldi, S; Lazzarini, E; Montecucco, F; Murialdo, R; Ruggeri, C; Spallarossa, P	1

Other Studies

1 other study(ies) available for capecitabine and glucagon-like peptide 1

Article	Year
5-fluorouracil causes endothelial cell senescence: potential protective role of glucagon-like peptide 1. British journal of pharmacology, 2017, Volume: 174, Issue:21 Topics: Aged; Antimetabolites, Antineoplastic; Blotting, Western; Capecitabine; Cell Line; Cellular Senescence; Endothelial Cells; Enzyme-Linked Immunosorbent Assay; Female; Fluorouracil; Glucagon-Like Peptide 1; Humans; Male; Reverse Transcriptase Polymerase Chain Reaction	2017

Article

Year

5-fluorouracil causes endothelial cell senescence: potential protective role of glucagon-like peptide 1.

British journal of pharmacology, 2017, Volume: 174, Issue:21

Topics: Aged; Antimetabolites, Antineoplastic; Blotting, Western; Capecitabine; Cell Line; Cellular Senescence; Endothelial Cells; Enzyme-Linked Immunosorbent Assay; Female; Fluorouracil; Glucagon-Like Peptide 1; Humans; Male; Reverse Transcriptase Polymerase Chain Reaction

2017